1 Cheap Pharmaceutical Stock to Buy in 2021
U.K.-based pharmaceutical GlaxoSmithKline (NYSE:GSK) has operations that cover the globe, a deep catalog of successful consumer and healthcare products, and an interesting pipeline of potential new treatments. But its share price is still down by about 21% from the five-year peak it hit in January 2020. Shares are also trading at a discount compared to historical valuations. In short, GlaxoSmithKline is on sale. Here's why you should consider taking advantage of that and adding the stock to your portfolio.
Image source: Getty Images.
GlaxoSmithKline was born from the merger of pharmaceutical companies Glaxo Wellcome and SmithKline Beecham, which brought along such well-known consumer products brands as Tums (heartburn), Sensodyne (toothpaste), and Nicorette (smoking cessation).
Source Fool.com
